The Judicial Panel on Multidistrict Litigation (JPML) published an order on December 15, 2025, approving a request to create a dedicated MDL for blindness claims filed by patients who took Zepbound or other GLP-1s
Because they target the brains reward centre, the mesolimbic system, they apparently do not just stop food noise but inadvertently the quiet joy found elsewhere
But know this: you have choices
Dosage begins at 3 mg daily for 30 days, then increases to 7 mg daily for at least 30 days, with potential escalation to 14 mg if additional glycemic control is needed
This integrated approach enables precise diagnosis, improved compliance, and long-term monitoring, ensuring that improvements are sustained and potential issues like weight regain or symptom recurrence are identified early
Similar observations were made in MDA-T32 and MDA-T68 PTC cell lines (Shown in Supplemental Fig